IP Library Granted Patent US 7,955,820
Granted Patent B1
US 7,955,820 · App. 12/833,821 · Granted Jun 7, 2011

Methods and compositions for the recombinant biosynthesis of n-alkanes

Assignee: Joule Unlimited, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,955,820
App. No.
12/833,821
Granted
Jun 7, 2011
Kind
B1
Abstract

The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently convert carbon dioxide and light into n-alkanes, and in particular the use of such organisms for the commercial production of n-alkanes and related molecules.

Claims (22)

1. A method for producing hydrocarbons, comprising:

(i) culturing an engineered cyanobacterium in a culture medium, wherein said engineered cyanobacterium comprises a recombinant acyl-ACP reductase enzyme and a recombinant alkanal decarboxylative monooxygenase enzyme, wherein at least one of said recombinant enzymes is heterologous with respect to said engineered cyanobacterium; and

(ii) exposing said engineered cyanobacterium to light and carbon dioxide, wherein said exposure results in the conversion of said carbon dioxide by said engineered cynanobacterium into n-alkanes, wherein the predominant n-alkane is n-pentadecane.

2. The method of claim 1 , wherein the amount of said n-alkanes produced is at least two times the amount produced by an otherwise identical cyanobacterium, cultured under identical conditions, but lacking said recombinant acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes.

3. The method of claim 1 , wherein said engineered cyanobacterium produces n-alkanes comprising both n-pentadecane and n-heptadecane, and wherein the percentage by mass of n-pentadecane relative to n-pentadecane plus n-heptadecane is at least 50%.

4. The method of claim 1 , further comprising isolating n-pentadecane from said engineered cyanobacterium or said culture medium.

5. The method of claim 1 , wherein said enzymes are encoded by a plasmid.

6. The method of claim 1 wherein said enzymes are encoded by recombinant genes incorporated into the genome of said engineered cyanobacterium.

7. The method of claim 1 wherein said enzymes are encoded by genes which are present in multiple copies in said engineered cyanobacterium.

8. The method of claim 1 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are at least 95% identical to SEQ ID NO: 10 and SEQ ID NO: 12, respectively.

9. The method of claim 1 , wherein said acyl-ACP reductase enzyme and said recombinant alkanal decarboxylative monooxygenase enzyme are encoded by genes which are part of an operon, and wherein the expression of said genes is controlled by one or more inducible promoters.

10. The method of claim 9 , wherein at least one promoter is a urea-repressible, nitrate-inducible promoter.

11. The method of claim 10 , wherein said urea-repressible, nitrate-inducible promoter is P(nir07).

12. The method of claim 1 , wherein said recombinant acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are least 95% identical to SEQ ID NO: 27 and SEQ ID NO: 29, respectively.

13. The method of claim 1 , wherein said engineered cyanobacterium comprises at least two operons encoding distinct alkanal decarboxylative monooxygenase and acyl-ACP reductase enzymes.

14. The method of claim 13 , wherein at least one operon encodes acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes which are at least 95% identical to SEQ ID NO: 27 and SEQ ID NO: 29, respectively.

15. The method of claim 13 , wherein at least one operon encodes acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes which are at least 95% identical to SEQ ID NO:10 and SEQ ID NO: 12, respectively.

16. The method of claim 6 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are at least 95% identical to SEQ ID NO:10 and SEQ ID NO:12, respectively.

17. The method of claim 16 , wherein expression of said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes is controlled by an inducible promoter.

18. The method of claim 17 , wherein said engineered cyanobacterium produces at least 0.5% DCW n-alkanes in the presence of an inducer.

19. The method of claim 17 , wherein said engineered cyanobacterium further comprises a second operon encoding acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes which are at least 95% identical to SEQ ID NO: 27 and SEQ ID NO: 29, respectively.

20. The method of claim 1 , wherein at least 95% of said n-alkanes, by mass, are n-pentadecane and n-heptadecane, and wherein the percentage by mass of n-pentadecane relative to n-pentadecane plus n-heptadecane is at least 80%.

Assignments (3)
SECURITY INTEREST Recorded Jun 23, 2016
From: JOULE UNLIMITED TECHNOLOGIES, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 039140/0200 →
CHANGE OF NAME Recorded Sep 20, 2011
From: JOULE UNLIMITED, INC.
To: JOULE UNLIMITED TECHNOLOGIES, INC.
Reel/Frame 026938/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2010
From: REPPAS, NIKOS BASIL; RIDLEY, CHRISTIAN PERRY
To: JOULE UNLIMITED, INC.
Reel/Frame 025027/0837 →
Continuity (3)
Continuation In Part 12759657 · Apr 13, 2010
Provisional Application 61228937 · Jul 27, 2009
Provisional Application 61224463 · Jul 9, 2009